tiprankstipranks
Trending News
More News >
Corline Biomedical AB (SE:CLBIO)
:CLBIO
Sweden Market

Corline Biomedical AB (CLBIO) Financial Statements

Compare
0 Followers

Corline Biomedical AB Financial Overview

Corline Biomedical AB's market cap is currently kr386.76M. The company's EPS TTM is kr-0.197; its P/E ratio is -25.47; Corline Biomedical AB is scheduled to report earnings on February 17, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 7.65Mkr 9.78Mkr 25.03Mkr 23.55Mkr 7.06M
Gross Profitkr -14.21Mkr 13.44Mkr 28.38Mkr 22.73Mkr 9.10M
Operating Incomekr -14.21Mkr -23.17Mkr -1.79Mkr 2.33Mkr -6.91M
EBITDAkr -14.12Mkr -23.07Mkr -1.69Mkr 2.38Mkr -6.88M
Net Incomekr -14.71Mkr -23.19Mkr -1.81Mkr 2.33Mkr -6.92M
Balance Sheet
Cash & Short-Term Investmentskr 20.56Mkr 17.67Mkr 17.01Mkr 26.21Mkr 41.63M
Total Assetskr 98.58Mkr 94.76Mkr 100.11Mkr 101.78Mkr 101.66M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -20.56Mkr -17.67Mkr -17.01Mkr -26.21Mkr -41.63M
Total Liabilitieskr 4.82Mkr 7.85Mkr 6.79Mkr 7.19Mkr 9.43M
Stockholders' Equitykr 93.76Mkr 86.91Mkr 93.32Mkr 94.59Mkr 92.23M
Cash Flow
Free Cash Flowkr -17.74Mkr -16.14Mkr -9.73Mkr -15.45Mkr -14.45M
Operating Cash Flowkr -17.69Mkr -8.64Mkr 886.00Kkr -6.45Mkr -4.83M
Investing Cash Flowkr -982.00Kkr -7.50Mkr -10.62Mkr -9.00Mkr -9.56M
Financing Cash Flowkr 21.56Mkr 16.79Mkr 537.00Kkr 26.00Kkr 47.13M
Currency in SEK

Corline Biomedical AB Earnings and Revenue History

Corline Biomedical AB Debt to Assets

Corline Biomedical AB Cash Flow

Corline Biomedical AB Forecast EPS vs Actual EPS